US 12,029,683 B2
Ocular implant and delivery system
Wendy Blanda, Irvine, CA (US); and Rhett Schiffman, Irvine, CA (US)
Assigned to Alcon Inc., Fribourg (CH)
Appl. No. 16/967,376
Filed by Alcon Inc., Fribourg (CH)
PCT Filed Feb. 19, 2019, PCT No. PCT/US2019/018559
§ 371(c)(1), (2) Date Aug. 4, 2020,
PCT Pub. No. WO2019/164834, PCT Pub. Date Aug. 29, 2019.
Claims priority of provisional application 62/633,823, filed on Feb. 22, 2018.
Prior Publication US 2021/0030590 A1, Feb. 4, 2021
Int. Cl. A61F 9/00 (2006.01); A61F 9/007 (2006.01); A61L 27/34 (2006.01)
CPC A61F 9/0017 (2013.01) [A61F 9/00781 (2013.01); A61L 27/34 (2013.01); A61F 2250/0002 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0096 (2013.01); A61L 2430/16 (2013.01)] 7 Claims
OG exemplary drawing
 
1. An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye, the implant comprising:
a tubular body having an inner surface and an outer surface and comprising a plurality of struts extending along a longitudinal axis of the tubular body and a plurality of open areas surrounded by the plurality of struts, the tubular body extending in a curved volume whose longitudinal axis forms an arc of a circle;
a polymer rod disposed within the curved volume of the tubular body;
at least one therapeutic agent disposed within an interstitial space of the polymer rod; and
the tubular body having a diameter of between 0.005 inches and 0.04 inches.